Why did SEQUA.BR stock jump pre-market today?

The pre-market rise to **€0.57** reflects short-covering and a technical rebound after prior weakness. No major company press release was filed; volume above average suggests traders repositioned ahead of the **25 March 2026** earnings date.

What is Meyka AI's 12-month forecast for SEQUA.BR stock?

Meyka AI's forecast model projects **€1.04** in 12 months, implying **+82.92%** versus the current **€0.57**. Forecasts are model-based projections and not guarantees.

What are the main risks for SEQUA.BR stock investors?

Key risks include ongoing cash burn, weak liquidity, negative EPS (**-1.23**), and possible dilution or debt refinancing. Clinical, regulatory, or reimbursement setbacks would also pressure the share price.

Which levels should traders watch for SEQUA.BR stock?

Watch short-term support at **€0.51–€0.52** and immediate resistance at the 50-day mean **€0.64** and 200-day mean **€0.94**. A sustained move above **€0.64** would improve the technical outlook.

EU Stocks

SEQUA.BR Sequana Medical NV EURONEXT pre-market +11.57% 23 Jan 2026: watch €0.57

ByHuzaifa Zahoor January 23, 2026

SEQUA.BR stock leads pre-market movers after a sharp morning rebound. The share price is trading at €0.57, up 11.57% versus the previous close, on 491,122.00 shares traded so far. The move follows heavy selling over 2025 and a stretched technical backdrop. Investors will watch the upcoming 25 March 2026 earnings date and sector flows in Healthcare on EURONEXT for confirmation of a sustainable recovery.